Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018

Chemistry, Manufacturing, and Controls (CMC) for an IND (7of14) REdI 2018
Share:

Download MP3


Similar Tracks

Benefit-Risk Considerations During Drug Product Development (8of14) REdI 2018 U.S. Food and Drug Administration
Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017 U.S. Food and Drug Administration
Sexually Transmitted Infections in Women – OWH Speaker Series U.S. Food and Drug Administration
Understanding FDA Inspections and Data U.S. Food and Drug Administration
MEDIA CALL: Front of Package Nutrition Labels – 1/14/2025 U.S. Food and Drug Administration
Bench to Bedside Chats: Guidance for Industry CGMP for Phase 1 Investigational Drugs U.S. Food and Drug Administration
BsUFA III Regulatory Science Pilot Program: Progress Update U.S. Food and Drug Administration
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018 U.S. Food and Drug Administration
CMC Considerations for CAR T Cell Product Development U.S. Food and Drug Administration
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic aci... U.S. Food and Drug Administration
Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018 U.S. Food and Drug Administration
Cervical Cancer Treatment Innovation: A Collaborative Discussion U.S. Food and Drug Administration
Updated "Healthy" Nutrient Content Claim: Final Rule – Webinar – 4/10/2025 U.S. Food and Drug Administration
Continuous Manufacturing of Drug Product (20of33) Quality – Oct. 16-17, 2019 U.S. Food and Drug Administration
Pregnancy and Lactation Medication Information for the Healthcare Provider | Learn More U.S. Food and Drug Administration
Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs U.S. Food and Drug Administration
Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI – May 29-30, 2019 U.S. Food and Drug Administration
January 10, 2025 Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) Meeting U.S. Food and Drug Administration
Navigating Controlled Correspondences to Support Generic Drug Development U.S. Food and Drug Administration
FDA Welcomes Dr. Martin A. Makary as 27th Commissioner of Food and Drugs – 4/2/2025 U.S. Food and Drug Administration